Marcus Dasilva Goncalves

NYU Grossman School of Medicine

NIH Rank #4442
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.2M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#4,442
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.2M across 6 grants · National rank #4442.

Top grants by award amount

Marcus Dasilva Goncalves's NIH grant portfolio, ranked by award amount.

  • 1OT2CA301505-01OT2
    The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer Cachexia
    $570.9K
    award amount
  • 5R01DK132427-03R01
    The role of PKM2 in dietary lipid absorption and fructose-induced obesity
    $540.4K
    award amount
  • 7R01CA279561-03R01
    Combination Therapies Targeting Insulin Signaling in Endometrial Cancer
    $507.7K
    award amount
  • 5R01CA258697-03R01
    Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival
    $379.2K
    award amount
  • 7R01CA258697-04R01
    Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival
    $221K
    award amount
  • 5R01CA279561-02R01
    Combination Therapies Targeting Insulin Signaling in Endometrial Cancer
    $1
    award amount

Affiliations

Institutions that have administered grants for Marcus Dasilva Goncalves.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    NYU Grossman School of Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4442
  6. 2024
    Entered Top 25% Nationally
    Ranked #4442
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions